Mitochondrial muaj nuj nqi tseem yog ib qho ntawm cov haujlwm tseem ceeb tshaj plaws ntawm kev tshawb nrhiav hauv kev laus hauv kev noj qab haus huv, kab mob metabolic thiab kev tshawb fawb tsis meej. Ntawm cov cuab yeej molecular siv los soj ntsuam mitochondrial membrane kev ncaj ncees thiab bioenergetics, SS-31 - cov hluavtaws hluavtaws-cationic tetrapeptide kuj paub los ntawm INN lub npe elamipretide, los yog MTP-131 - yog ib qhov dej -kev tshawb fawb cardiolipingets pide{5}.
Tsab ntawv xov xwm no tshuaj xyuas lub xeev tam sim no ntawm SS-31 kev tshawb fawb, tsim thiab tawm cov pov thawj kho mob, cov kev txwv kev txhais lus, thiab cov kev xav tau zoo thiab cov khoom lag luam uas tseem ceeb tshaj plaws rau kev tshawb fawb cov neeg yuav khoom thiab pab pawg muag khoom.
2026 Kev Tshawb Fawb Kev Pom Zoo
A 2026 cov phooj ywg- tau tshuaj xyuas hauvFrontiers hauv Physiologytshuaj xyuas cardiolipin remodeling raws li ib tug mitochondrial kho lub tswv yim, thiab ntsuam xyuas cov translational pov thawj saw rau elamipretide thiab lwm yam compounds. Cov kev ntsuam xyuas thav duabTSI-31raws li ib tug prototypical cardiolipin-binding peptide, thiab sib tham txog ob qho tib si lub ntsiab lus ntawm kev siv tshuab thiab qhov sib txawv ntawm cov kev soj ntsuam ua ntej thiab cov txiaj ntsig kho mob thoob plaws cov lus qhia.
Cov ntsiab lus tseem ceeb ntawm kev txheeb xyuas muaj xws li:
Cardiolipin stabilization yog ib txoj kev kho mob lom neeg uas muaj peev xwm txhawb nqa los ntawm cov ntaub ntawv kho mob muaj zog.
Mechanistic txhim kho nyob rau hauv mitochondrial respiration tsis ntseeg tau txhais mus rau hauv lub cev - theem kev pab cuam nyob rau hauv tag nrho cov kab mob.
Cov txiaj ntsig ntawm kev kho mob tseem qhia tau hais tias- tshwj xeeb, thiab cov txiaj ntsig hauv ib tus neeg tsis txhais tau tias muaj txiaj ntsig rau lwm tus.
Lub moj khaum no yog qhov tshwj xeeb tshaj yog rau kev tshawb fawb SS-31 hauv 2026, vim tias thaj chaw txav los ntawm cov yam ntxwv ntawm kev siv tshuab mus rau kev xaiv kho mob ntau dua.
Kev tshawb fawb keeb kwm
Nyob rau hauv nruab nrab ntawm SS-31 kev tshawb fawb yog cardiolipin, ib tug dimeric phospholipid heev enriched nyob rau hauv lub puab mitochondrial membrane. Cardiolipin tsis yog ib qho lipid structural; Nws txhawb cristae architecture, stabilizes respiratory saw supercomplexes, thiab tswj oxidative phosphorylation zoo. Nyob rau hauv cov xwm txheej ntawm oxidative kev nyuaj siab, kev laus thiab kab mob, cardiolipin peroxidation thiab depletion tuaj yeem cuam tshuam cov qauv ntawm daim nyias nyias, txo qis kev ua pa ntawm lub ntsws thiab pab txhawb rau mitochondrial tsis ua haujlwm.
Vim tias nws lub luag haujlwm tseem ceeb hauv kev noj qab haus huv mitochondrial, cov tebchaw uas cuam tshuam nrog cardiolipin thiab txhawb nqa lub koom haum membrane tau dhau los ua cov cuab yeej tshawb fawb tseem ceeb thoob plaws ntau thaj chaw kab mob.
Kev Tshawb Fawb Tam sim no tsom
Peb cov lus qhia tseem ceeb txuas ntxiv tsav SS-31 kev tshawb fawb hauv 2026:
Cov qauv kab mob thiab kev kho mob txhais lus
Kev ua haujlwm hauv tsev kho mob txuas ntxiv mus hla ischemia- raug mob rov ua dua, myopathies, mob raum thiab cov qauv neurodegeneration. Clinically, kev txhim kho feem ntau tseem yog lub Cuaj Hlis 2025 nrawm FDA pom zoo ntawm Forzinity ™ (elamipretide txhaj) rau kev txhim kho cov leeg nqaij hauv cov neeg laus thiab cov menyuam yaus nrog Barth syndrome uas hnyav li 30 kg. Kev pom zoo yog ua raws li lub hauv caug extensor leeg lub zog ua qhov nruab nrab qhov kawg, thiab tom qab- kev tshawb fawb txog kev lag luam yuav tsum tau ua.
Tshaj li Barth syndrome, elamipretide tau kawm nyob rau hauv ntxiv mitochondrial thiab cardiometabolic indications, nrog rau ntau theem ntawm cov pov thawj. Kev txhais lus ua tiav thoob plaws qhov taw qhia tseem yog thaj chaw tseem ceeb ntawm kev tshawb nrhiav thiab kev sib cav.Mitochondrial bioenergetics
Cov kev tshawb fawb txuas ntxiv mus tshawb xyuas seb daim nyias nyias - cov peptides lub hom phiaj cuam tshuam rau txoj kev ua pa ntawm txoj hlab pa, proton leak thiab ATP ntau lawm nyob rau hauv ob qho tib si so thiab kev ntxhov siab. Txoj haujlwm no txhawb nqa qhov laj thawj rau kev sim SS-31 hauv kev tsis txaus ntseeg ntawm lub zog.
Membrane qauv thiab stability
Biophysical thiab cellular ua hauj lwm txuas ntxiv qhia meej li cas peptide- kev sib cuam tshuam ntawm cov paj hlwb khaws cia lub koom haum cristae thiab txwv cardiolipin peroxidation thaum muaj kev ntxhov siab. Qhov no cardiolipin - phiajcim membrane stabilization qauv tseem yog qhov tseem ceeb ntawm cov txheej txheem ntawm kev txiav txim rau SS-31.
Yog xav paub ntxiv txog cov txheej txheem molecular, saib peb daim ntawv qhia tag nrho ntawm SS-31 mechanism ntawm kev ua.
Cov ntaub ntawv pov thawj thiab kev txwv
Cov ntaub ntawv pov thawj muaj zog sib txawv los ntawm hom kev kawm:
Mechanistic thiab biophysical kev tshawb fawb muab kev txhawb zog tshaj plaws rau cov qauv kev sib cuam tshuam ntawm cardiolipin.
Kev tshawb fawb txog kab lis kev cai ntawm tes tau tshawb xyuas mitochondrial ua pa thiab kev ntxhov siab nyob rau ntau hom cell.
Hauv vivo tsiaj kev tshawb fawb qhia tau hais tias muaj txiaj ntsig zoo hauv ntau tus qauv kab mob, tab sis qhov loj me txawv ntawm tus qauv, koob tshuaj thiab txoj hauv kev.
Tib neeg cov ntaub ntawv pov thawj kho mob feem ntau yog tsim los rau cov kev pom zoo tshwj xeeb thiab cov qauv tsim, thiab tseem txwv lossis sib xyaw rau lwm qhov kev qhia.
Cov txiaj ntsig kev kho mob tsis tau zoo ib yam ntawm cov lus qhia. Nyob rau theem 3 MMPOWER-3 kev sim hauv thawj mitochondrial myopathy, elamipretide tsis tau raws li nws cov ntsiab lus kawg rau rau -feeb taug kev deb lossis tag nrho qaug zog ntawm 24 lub lis piam. Qhov txiaj ntsig no qhia txog vim li cas kev tshawb pom los ntawm kev tshawb fawb txog kev siv tshuab, tsiaj qauv thiab ib tus neeg kho mob yuav tsum tsis txhob ua rau lwm yam kab mob yam tsis muaj pov thawj tshwj xeeb.
FDA pom zoo siv rau Forzinity, ib qho kev txhaj tshuaj elamipretide rau cov cim npe Barth syndrome. Nws yuav tsum tsis txhob muab txhais raws li kev pom zoo ntawm kev tshawb fawb -qib SS-31 peptide hmoov, lwm yam formulations los yog lwm yam kab mob qhia. Kev tswj hwm txoj cai thiab kev tso cai siv yuav tsum raug ntsuas cais rau txhua yam khoom thiab kev txiav txim.
Kev txiav txim siab zoo Peptide
Raws li kev tshawb fawb nce ntxiv, qhov zoo ntawm peptide raw khoom nws tus kheej tseem yog lub hauv paus tab sis feem ntau tsis pom zoo. Kev tshawb fawb nrog cov khoom siv tsis zoo tuaj yeem tsim cov txiaj ntsig sib txawv lossis tsis tuaj yeem tsim tau.
Cov ntsiab lus tseem ceeb rau kev tshawb nrhiav cov neeg yuav khoom muaj xws li:
Kev lees paub ntawm peptide tus kheej raug, tsis yog tus lej purity xwb
Qhov sib txawv ntawm HPLC chromatographic purity thiab peptide cov ntsiab lus tseeb los ntawm qhov hnyav
Batch-cov ntaub ntawv tshwj xeeb zoo, tsis yog cov ntawv txheeb xyuas cov khoom lag luam
Traceability ntawm daim ntawv pov thawj ntawm kev soj ntsuam thiab cov khoom siv
Rau cov pab pawg tshawb fawb, kev nqis peev hauv kev txheeb xyuas qhov zoo ntawm cov dej ntws los txo cov kev sim kev pheej hmoo qis qis. Rau ib daim ntawv teev npe zoo thiab COA, saib peb SS-31 peptide kev soj ntsuam zoo qhia.
B2B Kev Pom Zoo
Rau pawg neeg yuav khoom nrhiav SS-31, tus nqi qis tshaj ib gram tsis tshua muaj nqi zoo tshaj. Cov neeg yuav khoom yuav tsum sib piv cov khoom ntawm lub hauv paus ntawm:
Txoj kev txheeb xyuas tus kheej
Purity assay thiab xam hauv paus
Batch-cov ntaub ntawv tshwj xeeb
Lub sij hawm ua lub sij hawm, ntim thiab shipping tej yam kev mob
Tus neeg muab kev pab txhawb nqa
Xaus
SS-31 tseem yog cov cuab yeej tshawb fawb tseem ceeb rau mitochondrial biology, kev txhawb nqa los ntawm lub hauv paus dav ntawm cov pov thawj preclinical thiab txuas ntxiv kev soj ntsuam nyob rau hauv cov lus qhia xaiv, nrog cov txiaj ntsig sib txawv los ntawm kev qhia. 2025 FDA pom zoo rau Barth Syndrome sawv cev rau qhov tseem ceeb tshaj plaws kev txhais lus tseem ceeb, thaum kev kho mob dav dav ntxiv nrog rau kev tshawb fawb tsis tu ncua.
Rau cov neeg siv khoom tshawb fawb, kev nkag siab txog ob qho tib si scientific toj roob hauv pes thiab kev txiav txim siab zoo rau kev nrhiav khoom yog qhov tseem ceeb rau kev ua haujlwm rov ua dua tshiab.
Rau cov khoom specifications, batch documentation thiab bulk nrhiav kev xaiv, mus saib SS-31 Peptide Powder khoom nplooj.
Cov ntaub ntawv
US Food and Drug Administration.Forzinity (elamipretide) txhaj tshuaj - nrawm pom zoo. Cuaj hlis 2025.
Sparvero L., et al. (2026). Cardiolipin remodeling nyob rau hauv mitochondrial kev kho mob: translational pov thawj chains los ntawm elamipretide mus rau cov tswv yim tshiab.Pem hauv ntej Physiol. 17:1813119. https://doi.org/10.3389/fphys.2026.1813119
Szeto HH (2018). Cardiolipin- tsom peptides rau mitochondrial tsis ua haujlwm.Pharmacol Ther. 186:102-113.